5-Fluorouracil and cisplatin in the treatment of advanced oral cancer

By Andreadis C.   Vahtsevanos K.   Sidiras T.   Thomaidis I.   Antoniadis K.   Mouratidou D.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells

By                  

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1339-1345

Spandidos Publications

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Antitumor activity of combination treatment with gefitinib and docetaxel in EGFRTKIsensitive, primary resistant and acquired resistant human nonsmall cell lung cancer cells

By        

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2417-2422

Spandidos Publications

Access to resources Recommend Favorite

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells

By Kurebayashi Junichi   Nukatsuka Mamoru   Nagase Hideki   Nomura Tsunehisa   Hirono Mai   Yamamoto Yutaka   Sugimoto Yoshikazu   Oka Toshinori   Sonoo Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite